Protein aggregation and mitochondrial dysfunction are key factors in aging and in neurodegenerative disease, like Alzheimer?s disease. It is clear that full understanding of mechanisms that neurons employ to combat these toxic threats will be critical for development of clinical neuroprotective strategies. The Driscoll lab has found that C. elegans neurons can sort and throw out neuronal debris for remote degradation in a novel ?extracellular garbage elimination? strategy. We call such extrusions, which are large ~.4um membrane-surrounded vesicles that can include protein aggregates and mitochondria, ?exophers?. We speculate that trash expulsion complements known intracellular protein and organelle degradation pathways to help maintain homeostasis. Consistent with this idea, neurons that extrude aggregate-filled exophers maintain better functionality than neurons that did not produce exophers. We also speculate that the mechanism of aggregate/mitochondrial hand-off to neighboring cells might constitute a conserved process relevant to the spread of pathological materials in mammalian neurodegenerative disease. Advancing understanding of the newly discovered exopher biology is thus likely to be of high impact in the neuroscience field. My interests is focused on deciphering why and how mitochondria are selected for expulsion in exophers. Data suggest that dysfunctional mitochondria may be preferentially extruded, but understanding of the conditions for segregation of particular mitochondria into the exopher compartment, and the cellular machinery that mediates this distinction is in its infancy. I will utilize the powerful molecular genetic tools of C. elegans to investigate principal mechanisms that mark, move, and expel mitochondria within exophers.
My first aim i s to define conditions that induce production of mitochondrial exophers and verify that mitochondria are of poor health under such conditions. I will use genetic means to test a range of mitochondrially-focused damage (heteroplasmy, cristae disruption, quality control impairment) to reveal the types of mitochondrial dysfunction that provoke extrusion for remote degradation. I will also investigate the details by which mitochondrial superoxide elevation increases the production of mito-exophers using genetics, optogenetics tools, mitochondrial assessment tools and high resolution microscopy.
My second aim i s to identify genes that are required for mitochondrial exopher production. I will use RNAi approaches to test candidate gene sets (including some uniquely available to us based on proteomics of candidate mammalian mitochondrial-loaded exophers). Time permitting, I will also participate in an unbiased screen for genes that can modulate production of exophers. I will initiate a detailed mechanistic study of 1-2 conserved genes to contribute some of the first molecular understanding of the exopher-genesis pathway. Given the profound importance of mitochondria in all of biology, especially in neurodegenerative disease and aging, the work I plan should be significant in carving out a new research area highly relevant to human health.
Mitochondria produce energy, execute core steps in metabolism, modulate cellular calcium, and control life/death balance in neurons, so it is no surprise that the functional maintenance of mitochondria is critical for healthy neuronal aging and protection against neurodegenerative disease. The Driscoll lab recently discovered that adult C. elegans neurons can collect and expel mitochondria in large membrane-bound ?garbage? containing structures called exophers, revealing a novel cellular approach toward maintaining mitochondrial quality in the sending neuron. I will exploit powerful genetic and cell biological approaches applicable in the facile C. elegans model system to: 1) define the precise neuronal stresses that provoke mitochondrial extrusion, and 2) elaborate some of the molecular machinery devoted to mitochondrial selection and extrusion--a totally novel facet of mitochondrial maintenance likely relevant to human neurodegenerative disease.
